| 12491255 |
EPCAM binding fibronectin type III domains |
Russell C. Addis, Robert Kolakowski, Swapnil Kulkarni, Steven G. Nadler, Yanxia Xin |
2025-12-09 |
|
| 12351619 |
Serum albumin-binding fibronectin type III domains and uses thereof |
Yao Xin, Russell C. Addis |
2025-07-08 |
|
| 12304939 |
EGFR and C-met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2025-05-20 |
|
| 12291797 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Steven Jacobs |
2025-05-06 |
|
| 12239710 |
FN3 domain-siRNA conjugates and uses thereof |
Swapnil Kulkarni, Russell C. Addis, Steven G. Nadler, Yao Xin, Zhanna Druzina +2 more |
2025-03-04 |
|
| 12054534 |
Prostate specific membrane antigen binding fibronectin type iii domains |
Rosa Cardoso, Michael Diem, Shalom Goldberg, Linus Hyun, Steven Jacobs +2 more |
2024-08-06 |
$410,876,000 |
| 12037379 |
CD71 binding fibronectin type III domains |
Russell C. Addis, Zhanna Druzina, Robert Kolakowski, Steven G. Nadler, Yao Xin |
2024-07-16 |
|
| 11833190 |
Serum albumin-binding fibronectin type III domains |
Michael Diem, Steven Jacobs, Thomas J. Rutkoski |
2023-12-05 |
$229,667,000 |
| 11781138 |
FN3 domain-siRNA conjugates and uses thereof |
Russell C. Addis, Zhanna Druzina, Robert Kolakowski, Swapnil Kulkarni, Steven G. Nadler +1 more |
2023-10-10 |
|
| 11702475 |
Cysteine engineered fibronectin type III domain binding molecules |
Shalom Goldberg, Steven Jacobs, Tricia Lin |
2023-07-18 |
$328,585,000 |
| 11628222 |
CD71 binding fibronectin type III domains |
Russell C. Addis, Zhanna Druzina, Robert Kolakowski, Swapnil Kulkarni, Steven G. Nadler +1 more |
2023-04-18 |
|
| 11479880 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Steven Jacobs |
2022-10-25 |
$370,166,000 |
| 11072663 |
Cysteine engineered fibronectin type III domain binding molecules |
Shalom Goldberg, Steven Jacobs, Tricia Lin |
2021-07-27 |
$445,875,000 |
| 10954284 |
EGFR and c-Met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2021-03-23 |
$120,756,000 |
| 10925932 |
Serum albumin-binding fibronectin type III domains |
Michael Diem, Steven Jacobs, Thomas J. Rutkoski |
2021-02-23 |
$143,700,000 |
| 10844111 |
Prostate specific membrane antigen binding fibronectin type III domains |
Rosa Cardoso, Michael Diem, Shalom Goldberg, Linus Hyun, Steven Jacobs +2 more |
2020-11-24 |
$91,850,000 |
| 10844122 |
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof |
Glenn Mark Anderson, Rosa Cardoso, Michael Diem, Francois Gaudet, Shalom Goldberg +15 more |
2020-11-24 |
$91,850,000 |
| 10662235 |
Cysteine engineered fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +5 more |
2020-05-26 |
$121,919,000 |
| 10654913 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Steven Jacobs |
2020-05-19 |
$146,179,000 |
| 10196446 |
Cysteine engineered fibronectin type III domain binding molecules |
Shalom Goldberg, Steven Jacobs, Tricia Lin |
2019-02-05 |
$80,901,000 |
| 10040842 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Steven Jacobs |
2018-08-07 |
$78,997,000 |
| 9725497 |
EGFR and C-Met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2017-08-08 |
$80,530,000 |
| 9695228 |
EGFR and c-Met fibronectin type III domain binding molecules |
Anderson Mark, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2017-07-04 |
|
| 9206244 |
IL4/IL13 binding repeat proteins and uses |
Michael Baumann, Gaby Tresch, Steven Jacobs |
2015-12-08 |
$65,625,000 |
| 9200059 |
Fibronectin type III domain based scaffold compositions, methods and uses |
Steve Jacobs |
2015-12-01 |
$88,743,000 |
